| # | Drug | Count |
|---|---|---|
| 0 | FOSCARBIDOPA/FOSLEVODOPA | 115 |
| 1 | ACETAMINOPHEN | 48 |
| 2 | ACETAMINOPHEN 500MG | 36 |
| 3 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 36 |
| 4 | PAIN RELIEVER | 36 |
| 5 | DIPHENHYDRAMINE HYDROCHLORIDE | 33 |
| 6 | ERGOCALCIFEROL | 30 |
| 7 | TREPROSTINIL | 25 |
| 8 | MACITENTAN | 24 |
| 9 | SODIUM CHLORIDE | 22 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | FOSCARBIDOPA/FOSLEVODOPA | 115 | 0.0130 |
| 1 | CASTOR OIL | 1 | 0.0052 |
| 2 | GRISEOFULVIN | 1 | 0.0034 |
| 3 | ENTACAPONE | 11 | 0.0026 |
| 4 | DIPHENHYDRAMINE HYDROCHLORIDE, ZINC ACETATE | 2 | 0.0024 |
| 5 | GOLODIRSEN | 1 | 0.0020 |
| 6 | IDURSULFASE | 8 | 0.0020 |
| 7 | ANTIHEMOPHILIC FACTOR, HUMAN RECOMBINANT | 1 | 0.0018 |
| 8 | ETEPLIRSEN | 4 | 0.0017 |
| 9 | PILOCARPINE HYDROCHLORIDE OPHTHALMIC SOLUTION | 2 | 0.0017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 76 |
| 1 | Prostacycline Vasodilator [EPC] | 34 |
| 2 | Corticosteroid [EPC] | 33 |
| 3 | Endothelin Receptor Antagonist [EPC] | 33 |
| 4 | Osmotic Laxative [EPC] | 29 |
| 5 | Benzodiazepine [EPC] | 27 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 25 |
| 7 | Proton Pump Inhibitor [EPC] | 25 |
| 8 | Aromatic Amino Acid [EPC] | 22 |
| 9 | HER2/neu Receptor Antagonist [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tubulin Inhibiting Agent [EPC] | 1 | 0.0034 |
| 1 | Catechol-O-Methyltransferase Inhibitor [EPC] | 11 | 0.0022 |
| 2 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 17 | 0.0013 |
| 3 | Plasma Kallikrein Inhibitor [EPC] | 2 | 0.0008 |
| 4 | Aromatic Amino Acid Decarboxylation Inhibitor [EPC] | 18 | 0.0006 |
| 5 | Antisense Oligonucleotide [EPC] | 6 | 0.0005 |
| 6 | Human Immunoglobulin G [EPC] | 10 | 0.0005 |
| 7 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 4 | 0.0004 |
| 8 | Antifibrinolytic Agent [EPC] | 4 | 0.0004 |
| 9 | Aromatic Amino Acid [EPC] | 22 | 0.0004 |